KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Change in Cash (2020 - 2026)

AbCellera Biologics filings provide 7 years of Change in Cash readings, the most recent being -$51.4 million for Q1 2026.

  • Quarterly Change in Cash fell 1849.4% to -$51.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$82.8 million through Mar 2026, down 331.85% year-over-year, with the annual reading at -$28.4 million for FY2025, 223.3% down from the prior year.
  • Change in Cash hit -$51.4 million in Q1 2026 for AbCellera Biologics, down from $44.8 million in the prior quarter.
  • Across five years, Change in Cash topped out at $245.8 million in Q2 2022 and bottomed at -$417.4 million in Q3 2022.
  • Average Change in Cash over 5 years is -$23.4 million, with a median of -$9.3 million recorded in 2025.
  • The largest annual shift saw Change in Cash soared 286.42% in 2024 before it tumbled 1849.4% in 2026.
  • AbCellera Biologics' Change in Cash stood at $14.6 million in 2022, then plummeted by 368.51% to -$39.1 million in 2023, then soared by 175.92% to $29.7 million in 2024, then skyrocketed by 50.92% to $44.8 million in 2025, then crashed by 214.84% to -$51.4 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Change in Cash are -$51.4 million (Q1 2026), $44.8 million (Q4 2025), and -$9.3 million (Q3 2025).